The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Mutations of the VHL tumour suppressor gene in renal carcinoma
Abstract
Multiple, bilateral renal carcinomas are a frequent occurrence in von Hippel-Lindau (VHL) disease. To elucidate the aetiological role of the VHL gene in human kidney tumorigenesis, localized and advanced tumours from 110 patients with sporadic renal carcinoma were analysed for VHL mutations and loss of heterozygosity (LOH). VHL mutations were identified in 57% of clear cell renal carcinomas analysed and LOH was observed in 98% of those samples. Moreover, VHL was mutated and lost in a renal tumour from a patient with familial renal carcinoma carrying the constitutional translocation, t(3;8)(p14;q24). The identification of VHL mutations in a majority of localized and advanced sporadic renal carcinomas and in a second form of hereditary renal carcinoma indicates that the VHL gene plays a critical part in the origin of this malignancy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In ccRCC, VHL loss impairs degradation of HIF-α proteins, leading to HIF accumulation irrespective of oxygen levels (Gnarra et al., 1994;Krieg et al., 2000).”
From Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer (2016) · cites this paper as Gnarra et al., 1994
In the citing paper
“In addition, most sporadic ccRCCs lose VHL function through genomic alterations”
From Hypoxic control of metastasis (2016) · cites this paper as [25]
Citations
Cites
Identification of the von Hippel-Lindau Disease Tumor Suppressor Gene
Latif, F., Tory, K., Gnarra, J. R., Yao, M., Duh, F.-M. C., Orcutt, M. L., Stackhouse, T. M., Kuzmin, I., Modi, W. S., Geil, L., et al. (1993) · Science · doi:10.1126/science.8493574 · Cited by 2,971
Self-citationThe Results of Radical Nephrectomy for Renal Cell Carcinoma
Robson, C. J., Churchill, B. M., & Anderson, W. D. (1969) · The Journal of Urology · doi:10.1016/s0022-5347(17)62331-0 · Cited by 1,303
Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC
Donis-Keller, H., Dou, S., Chi, D., Carlson, K. M., Toshima, K., Lairmore, T. C., Howe, J. R., Moley, J. F., Goodfellow, P. J., & Wells, S. A. (1993) · Human Molecular Genetics · doi:10.1093/hmg/2.7.851 · Cited by 1,298
Hereditary cancer, oncogenes, and antioncogenes.
Knudson, A. G. (1985) · PubMed · Cited by 1,218
The Results of Radical Nephrectomy for Renal Cell Carcinoma
Robson, C. J., Churchill, B. M., & Anderson, W. D. (2016) · The Journal of Urology · doi:10.1016/j.juro.2016.10.095 · Cited by 1,160
Hofstra, R. M. W., Landsvater, R. M., Ceccherini, I., Stulp, R. P., Stelwagen, T., Luo, Y., Pasini, B., Höppener, J. W. M., van Amstel, H. K. P., Romeo, G., et al. (1994) · Nature · doi:10.1038/367375a0 · Cited by 1,143
Strauss, M. B., & Welt, L. G. (1963) · Little, Brown eBooks · Cited by 823
Mutations of the RET proto-oncogene in Hirschsprung's disease
Edery, P., Lyonnet, S., Mulligan, L. M., Pelet, A., Dow, E., Abel, L., Holder, S., Nihoul‐Feketé, C., Ponder, B. A. J., & Münnich, A. (1994) · Nature · doi:10.1038/367378a0 · Cited by 746
Romeo, G., Ronchetto, P., Luo, Y., Barone, V., Seri, M., Ceccherini, I., Pasini, B., Bocciardi, R., Lerone, M., Kääriäinen, H., et al. (1994) · Nature · doi:10.1038/367377a0 · Cited by 698
Specific mutations of the RET proto-oncogene are related to disease phenotype in MEN 2A and FMTC
Mulligan, L. M., Eng, C., Healey, C. S., Clayton, D. G., Kwok, J. B., Gardner, E., Ponder, M. A., Frilling, A., Jackson, C. E., Lehnert, H., et al. (1994) · Nature Genetics · doi:10.1038/ng0194-70 · Cited by 643
Hereditary Renal-Cell Carcinoma Associated with a Chromosomal Translocation
Cohen, A. J., Li, F. P., Berg, S., Marchetto, D. J., Tsai, S., Jacobs, S. C., & Brown, R. S. (1979) · New England Journal of Medicine · doi:10.1056/nejm197909133011107 · Cited by 643
Von Hippel-Lindau disease: a genetic study.
Maher, E. R., Iselius, L., Yates, J. R. W., Littler, M., Benjamin, C. M., Harris, R., Sampson, J. R., Williams, A., Ferguson-Smith, M. A., & Morton, N. E. (1991) · Journal of Medical Genetics · doi:10.1136/jmg.28.7.443 · Cited by 597
Von Hippel-Lindau Disease Affecting 43 Members of a Single Kindred
Lamiell, J. M., Salazar, F. G., & Hsia, Y. E. (1989) · Medicine · doi:10.1097/00005792-198901000-00001 · Cited by 366
Cytogenetics of papillary renal cell tumors
Kovács, G., FÜZESI, L., Emanuel, A. R., & Kung, H. (1991) · Genes Chromosomes and Cancer · doi:10.1002/gcc.2870030403 · Cited by 316
Hereditary Papillary Renal Cell Carcinoma
Zbar, B., Tory, K., Merino, M. J., Schmidt, L. S., Glenn, G. M., Choyke, P. L., Walther, M. M., Lerman, M. I., & Linehan, W. M. (1994) · The Journal of Urology · doi:10.1016/s0022-5347(17)35015-2 · Cited by 305
Self-citationImportant advances in oncology 1994
Holmes, M. E. (1994) · Surgical Oncology · doi:10.1016/0960-7404(94)90075-2 · Cited by 283
Molecular analysis of genetic changes in the origin and development of renal cell carcinoma.
Anglard, P., Tory, K., Brauch, H. B., Weiss, G. H., Latif, F., Merino, M. J., Lerman, M. I., Zbar, B., & Linehan, W. M. (1991) · PubMed · Cited by 178
Self-citationPapillary renal cell carcinoma. A morphologic and cytogenetic study of 11 cases.
Kovács, G. (1989) · PubMed · Cited by 177
Establishment and characterization of human renal cancer and normal kidney cell lines.
Ebert, T., Bander, N. H., Finstad, C. L., Ramsawak, R. D., & Old, L. J. (1990) · PubMed · Cited by 153
Self-citationCytogenetic and molecular genetic studies of follicular and papillary thyroid cancers.
Herrmann, M. A., HAY, I. D., Bartelt, D. H., Ritland, S., Dahl, R. J., Grant, C. S., & Jenkins, R. B. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115472 · Cited by 135
Molecular and cellular characterization of human renal cell carcinoma cell lines.
Anglard, P., Trahan, E. E., Liu, S., Latif, F., Merino, M. J., Lerman, M. I., Zbar, B., & Linehan, W. M. (1992) · PubMed · Cited by 107
Self-citationChromosome 17p deletions and p53 mutations in renal cell carcinoma.
Reiter, R. E., Anglard, P., Liu, S., Gnarra, J. R., & Linehan, W. M. (1993) · PubMed · Cited by 102
Self-citationMakos, M., Nelkin, B. D., Reiter, R. E., Gnarra, J. R., Brooks, J. D., Isaacs, W. B., Linehan, W. M., & Baylin, S. B. (1993) · PubMed · Cited by 98
Self-citationLi, F. P., Decker, H.-J. H., Zbar, B., Stanton, V. P., Kovacs, G., Seizinger, B. R., Aburatani, H., Sandberg, A. A., Berg, S., Hosoe, S., et al. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-118-2-199301150-00005 · Cited by 82
Self-citationTumor Suppressor Gene Allelic Loss in Human Renal Cancers
Brooks, J. D., Bova, G. S., Marshall, F. F., & Isaacs, W. B. (1993) · The Journal of Urology · doi:10.1016/s0022-5347(17)35760-9 · Cited by 47
Self-citationHuman renal carcinoma: Characterization of five new cell lines
Grossman, H. B., Wedemeyer, G., & Ren, L. (1985) · Journal of Surgical Oncology · doi:10.1002/jso.2930280320 · Cited by 40
Self-citationLoss of heterozygosity on the short arm of chromosome 3 in mesothelioma cell lines and solid tumors
Zeiger, M. A., Gnarra, J. R., Zbar, B., Linehan, W. M., & Pass, H. I. (1994) · Genes Chromosomes and Cancer · doi:10.1002/gcc.2870110104 · Cited by 34
Self-citationGenetic basis of renal cell cancer.
Linehan, W. M., Gnarra, J. R., Mi, L., Latif, F., & Zbar, B. (1993) · PubMed · Cited by 18
Self-citationEstablishment and characterization of a cell line (SS78) from a human renal cell carcinoma
Shrivastav, S., Sharief, Y., Day, J., Reich, C. F., & Bonar, R. A. (1981) · In Vitro Cellular & Developmental Biology - Plant · doi:10.1007/bf02618614 · Cited by 8
Flagged first, then by citations
Research works printed but not linked: 1
- Glenn, G.M., Choyke, P.L., Zbar, B. & Linehan, W.M. von Hippel-Lindau disease: clinical review and molecular genetics. Problems Urol. 4, 312–330 (1990).
Cited by
Sorted by citations
Sunitinib versus Interferon Alfa in Metastatic Renal-Cell Carcinoma
Motzer, R. J., Hutson, T. E., Tomczak, P., Michaelson, M. D., Bukowski, R. M., Rixe, O., Oudard, S. M., Négrier, S., Szczylik, C. A., Kim, S. T., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa065044 · Cited by 5,752
Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands.
Herman, J. G., Graff, J. R., Myöhänen, S., Nelkin, B. D., & Baylin, S. B. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.18.9821 · Cited by 5,634
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180
Hsieh, J. J., Purdue, M. P., Signoretti, S., Swanton, C., Albiges, L., Schmidinger, M., Heng, D. Y., Larkin, J., & Ficarra, V. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.9 · Cited by 2,426
Yang, J. C., Haworth, L. R., Sherry, R. M., Hwu, P., Schwartzentruber, D. J., Topalian, S. L., Steinberg, S. M., Chen, H. X., & Rosenberg, S. A. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021491 · Cited by 2,704
Metadata
- Authors
- Gnarra, J. R., Tory, K., Weng, Y., Schmidt, L., Wei, M. H., Li, H., Latif, F., Liu, S., Chen, F., Duh, F.-M., Lubensky, I., Duan, D. R., Florence, C., Pozzatti, R., Walther, M. M., Bander, N. H., Grossman, H. B., Brauch, H., Pomer, S., Brooks, J. D., Isaacs, W. B., Lerman, M. I., Zbar, B., & Linehan, W. M.
- Affiliations
- National Cancer Institute (US)
- Frederick National Laboratory for Cancer Research (US)
- National Institutes of Health (US)
- Cornell University (US)
- University of Michigan (US)
- Technical University of Munich (DE)
- Heidelberg University (DE)
- Johns Hopkins University (US)
- ORCID
- Venue
- Nature Genetics
- Published
- 1994-05
- Volume
- 7
- Issue
- 1
- Pages
- 85-90
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W2010160635
- Cited by
- 1,730
- References
- 29
- Citations by year
- 2026: 17 · 2025: 25 · 2024: 30 · 2023: 38 · 2022: 38 · 2021: 45 · 2020: 56 · 2019: 47 · 2018: 45 · 2017: 42 · 2016: 57 · 2015: 35 · 2014: 70 · 2013: 66 · 2012: 62
- FWCI
- 61.77
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Renal cell carcinoma treatment
- Health Sciences › Medicine › Oncology › Ear and Head Tumors
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Keywords
- VHL gene, von Hippel-Lindau disease, renal carcinoma, clear cell renal cell carcinoma, loss of heterozygosity
- MeSH terms
- Base Sequence, Carcinoma, DNA Mutational Analysis, DNA, Neoplasm, von Hippel-Lindau Disease, Humans, Kidney Neoplasms, Molecular Sequence Data, Mutation, Organ Specificity, Polymorphism, Restriction Fragment Length, Genes, Tumor Suppressor, Neoplasms, Second Primary, Sequence Deletion, Adenocarcinoma, Clear Cell
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
